the injection is potent
In 2010, TYSABRI clinical trial data were used to define a new outcome: freedom from disease activity, 15 defined as absence of EDSS progression, relapse, or new/newly enlarging MS lesions
In a multicenter, randomized, controlled trial in patients with venous leg ulcers, among those with ulcers of less than 12 months duration, significantly more of those treated with Dermagraft plus compression therapy were healed by week 12 than control participants treated with compression therapy alone (Harding 2013)
J Pharmacol Exp Ther 327:770776 Zhang L, Hanigan MH (2003) Role of cysteine S -conjugate -lyase in the metabolism of cisplatin
The latter, through the formation of ROS, cause direct membrane damage triggering the genesis of a vicious circle inflammatory process that underlies the pathogenesis of AD ( The pathophysiology of AD is complex, combining genetic predisposition and impaired epidermal barrier function with an unbalanced inflammatory response to environmental factors ( The high production of ROS can induce autophagy, apoptosis and programmed necrosis in cells, resulting in DNA damage and skin barrier breakdown ( The aim of this narrative review is to summarize the latest evidence on the role of ROS and oxidative stress in the development of AD and to provide an overview of the studies on the effects of exogenous antioxidants in prevention and treatment of patients with AD
